Show simple item record

dc.contributor.authorColice, Gene
dc.contributor.authorPrice, David
dc.contributor.authorGerhardsson de Verdier, Maria
dc.contributor.authorRabon-Stith, Karma
dc.contributor.authorAmbrose, Christopher
dc.contributor.authorCappell, Katherine
dc.contributor.authorIrwin, Debra E.
dc.contributor.authorJuneau, Paul
dc.contributor.authorVlahiotis, Anna
dc.contributor.authorRespiratory Effectiveness Group (REG)
dc.date.accessioned2017-12-06T17:46:23Z
dc.date.available2017-12-06T17:46:23Z
dc.date.issued2017-12-01
dc.identifier.citationColice , G , Price , D , Gerhardsson de Verdier , M , Rabon-Stith , K , Ambrose , C , Cappell , K , Irwin , D E , Juneau , P , Vlahiotis , A & Respiratory Effectiveness Group (REG) 2017 , ' The effect of DPP-4 inhibitors on asthma control : an administrative database study to evaluate a potential pathophysiological relationship ' Pragmatic and Observational Research , vol. 2017 , no. 8 , pp. 231-240 . https://doi.org/10.2147/POR.S144018en
dc.identifier.issn1179-7266
dc.identifier.otherPURE: 112674858
dc.identifier.otherPURE UUID: 8ee25a1b-232b-4933-9f03-06c3b1a5c6c8
dc.identifier.urihttp://hdl.handle.net/2164/9730
dc.descriptionAcknowledgments The authors acknowledge Koustubh Ranade (MedImmune, Gaithersburg, MD, USA) and Stephen Johnston, a member of the steering committee who was employed by Truven Health Analytics at the time the study was conducted, for their contributions to this study . Truven Health Analytics, an IBM Company, received funding from AstraZeneca in relation to this study. This work was previously presented as a poster at the annual international conference of the American Thoracic Society, May 19–24, 2017, Washington, DC (Colice G, et al. The Effect of Dipeptidyl-Peptidase-4 Inhibitors on Asthma Control: An Administrative Database Study to Evaluate a Potential Pathophysiological Relationship. Am J Respir Crit Care Med. 2017;195:A3050).en
dc.format.extent10en
dc.language.isoeng
dc.relation.ispartofPragmatic and Observational Researchen
dc.rights© 2017 Colice et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms. php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php)en
dc.subjectasthma controlen
dc.subjectDPP-4ien
dc.subjecttype 2 diabetesen
dc.subjectR Medicine (General)en
dc.subject.lccR1en
dc.titleThe effect of DPP-4 inhibitors on asthma control : an administrative database study to evaluate a potential pathophysiological relationshipen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen, Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen, Other Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.2147/POR.S144018


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record